Skip to main content

Table 2 Ultrasonic evaluation outcomes at baseline and 3 month after the procedure in two groups

From: Ultrasound-guided needle release of the transverse carpal ligament with and without corticosteroid injection for the treatment of carpal tunnel syndrome

 

Group A (N = 25)

Group B (N = 25)

 

Baseline

Postprocedure

Baseline

Postprocedure

Flattening ratio of median nerve at the level of hamate bone

3.45 ± 0.75

3.18 ± 0.56a

3.42 ± 0.81

3.30 ± 0.41a,b

Cross-sectional area of the MN at the level of pisiform bone (cm2)

0.14 ± 0.02

0.10 ± 0.01a

0.14 ± 0.02

0.12 ± 0.01a,b

TCL thicknesses on the cross-section at the level of hamate bone (cm)

0.31 ± 0.07

0.15 ± 0.06a

0.32 ± 0.04

0.18 ± 0.05a,b

  1. a, vs baseline, P < 0.05; b, vs Group A; Group A, ultrasound-guided needle release of the transverse carpal ligament plus corticosteroid injection; Group B, single ultrasound-guided needle release of the transverse carpal ligament; LR, Left-right; AP, Anteroposterior; MN, median nerve